RICHTECH ROBOTICS INC.
Business
RICHTECH ROBOTICS INC. designs, manufactures and sells advanced robotic technologies and a cloud-based management platform to automate labor-intensive services in hospitality, healthcare and other sectors. It offers autonomous mobile robots for indoor transport and delivery (Matradee, Medbot, Titan, Skylark), sanitation robots (DUST-E S and MX), and food and beverage automation systems (ADAM, Scorpion), plus the ACP and deployment, maintenance and Robot-as-a-Service offerings. Key business segments include product hardware, ACP software and services, and hospitality operations via Alphamax/Clouffee franchise initiatives. Richtech distributes primarily across the United States and is expanding internationally through distributors, enterprise partnerships, franchises and retail integrations such as Walmart.
Summary from filing dated 2025-01-14
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 |
|---|---|---|---|---|---|
| Revenue, net | 5 | 4 | 9 | 6 | |
| Cost of revenue, net | 2 | 2 | 3 | 2 | |
| Gross profit | 3 | 3 | 6 | 4 | |
| Research and development | 2 | 2 | 2 | 2 | |
| Sales and marketing | 1 | 1 | 238,000 | 297,000 | |
| General and administrative | 18 | 6 | 4 | 2 | |
| Total operating expenses | 21 | 10 | 6 | 4 | |
| Income (loss) from operations | −18 | −7 | 289,000 | −376,000 | |
| Investment Income | 2 | 13,000 | — | — | |
| Interest expense, net | −83,000 | −762,000 | — | — | |
| Total other expense | 2 | −749,000 | −734,000 | — | |
| Loss before income tax expense | −16 | −8 | −445,000 | −394,000 | |
| Income tax benefit/(expense) | −12,000 | −318,000 | 106,000 | −113,000 | |
| Consolidated net loss | −16 | −8 | — | — | |
| Less: Net loss Attributable to Non-Controlling Interest | −108,000 | — | — | — | |
| Net loss | −16 | −8 | −339,000 | −507,000 | |
| Net loss attributable to common stockholders | −16 | −8 | −339,000 | −507,000 | |
| Basic net loss per share of common stock (in Dollars per share) | −0.13 | −0.12 | −0.01 | −0.01 | |
| Diluted net loss per share of common stock (in Dollars per share) | −0.13 | −0.12 | −0.01 | −0.01 | |
| Weighted average shares used to compute basic net loss per share (in Shares) | 122 | 70 | 62 | 40 | |
| Weighted average shares used to compute diluted net loss per share (in Shares) | 122 | 70 | 62 | 40 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 | FY 2021 2021-09-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 194 | 15 | 433,000 | 327,000 | — | |
| Short term investment | 58 | 16 | — | — | — | |
| Accounts receivable, (net of allowance for doubtful accounts) | 2 | 1 | 6 | 2 | — | |
| Inventory | 1 | 1 | 822,000 | 1 | — | |
| Prepaid expenses and other current assets | 429,000 | 33,000 | 17,000 | 41,000 | — | |
| Total current assets | 256 | 33 | 7 | 4 | — | |
| Property and equipment, net | 6 | 738,000 | 28,000 | 41,000 | — | |
| Notes revievable | 523,000 | — | — | — | — | |
| Operating lease right-of-use-assets | 731,000 | 506,000 | 315,000 | 382,000 | — | |
| Intangible assets, Net | 10 | 8 | — | — | — | |
| Other assets, non-current | 638,000 | 740,000 | 10,000 | 10,000 | — | |
| Total assets | 273 | 43 | 8 | 4 | — | |
| Accounts payable | 397,000 | 150,000 | 1 | 175,000 | — | |
| Deferred revenue | 248,000 | — | — | — | — | |
| Accrued expenses and other payables | 1 | 97,000 | — | — | — | |
| Short-term loan | — | 53,000 | 845,000 | — | — | |
| Tax payables | 55,000 | 5,000 | 461,000 | 117,000 | — | |
| Operating lease liabilities, current | 301,000 | 150,000 | 161,000 | 108,000 | — | |
| Total current liabilities | 2 | 455,000 | 3 | 741,000 | — | |
| Long-term payables | 118,000 | 102,000 | — | — | — | |
| Operating lease liabilities, non-current | 429,000 | 356,000 | 154,000 | 279,000 | — | |
| Total liabilities | 3 | 913,000 | 3 | 1 | — | |
| Commitments and contingencies (Notes 7) | — | — | — | — | — | |
| Additional Paid-in Capital | 293 | 50 | 5 | 2 | — | |
| Accumulated other comprehensive income | 393,000 | — | — | — | — | |
| Retained earnings | −24 | −8 | 201,000 | 540,000 | — | |
| Total controlling stockholders equity | 270 | 42 | 5 | 3 | 2 | |
| Non-controlling interests | −43,000 | — | 5 | 3 | — | |
| Total stockholders equity | 270 | 42 | 5 | — | — | |
| Total liabilities and stockholders equity | 273 | 43 | 8 | 4 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-09-30 | FY 2024 2024-09-30 | FY 2023 2023-09-30 | FY 2022 2022-09-30 |
|---|---|---|---|---|---|
| Accounts receivable | −421,000 | 4 | −4 | −2 | |
| Inventory | −232,000 | −326,000 | 551,000 | −389,000 | |
| Prepaid expenses and other current assets | −396,000 | −16,000 | 23,000 | −31,000 | |
| Right-of-use asset | −225,000 | −191,000 | 67,000 | −382,000 | |
| Accounts payable | 247,000 | −976,000 | 951,000 | −305,000 | |
| Deferred revenue | 248,000 | — | — | — | |
| Tax payable | 50,000 | −456,000 | 344,000 | — | |
| Accrued expenses and other payable | 1 | 38,000 | 3,000 | 28,000 | |
| Deferred Tax assets | — | 518,000 | −518,000 | — | |
| Depreciation and amortization | 2 | 81,000 | 13,000 | — | |
| Stock based compensation | 4 | — | — | — | |
| Non-Operating Losses | −108,000 | — | — | — | |
| Operating lease liabilities, current | 152,000 | −12,000 | — | — | |
| Operating lease liabilities, non- current | 73,000 | 202,000 | 36,000 | 279,000 | |
| Net cash provided by operating activities | −9 | −5 | −3 | −3 | |
| Purchase of PPE | −5 | −725,000 | — | — | |
| Purchase of intangible assets | −591,000 | −5 | — | — | |
| Purchase of short-term investments | −42 | −16 | — | — | |
| Purchase of long-term investments | 102,000 | −730,000 | — | — | |
| Notes receivable | −523,000 | — | — | — | |
| Cash used for lending to related parties | — | 134,000 | −30,000 | — | |
| Net cash used in investing activities | −48 | −23 | −26,000 | −44,000 | |
| Payment of loans received from third parties | −53,000 | −4 | — | — | |
| Contributions from Non-controlling Interests | 65,000 | — | — | — | |
| Proceeds from warrants exercise | 16 | — | — | — | |
| Loans received from third parties | 16,000 | 3 | — | — | |
| Loan settlement | — | 3 | — | — | |
| Payment of related party debt | — | −238,000 | −247,000 | — | |
| Proceeds from issuance of ordinary shares | 220 | 30 | — | — | |
| Proceeds from stockholder capital injection | — | 9 | 2 | 2 | |
| Net Cash used in financing activities | 236 | 42 | 3 | 2 | |
| Net change in cash and cash equivalents | 179 | 14 | — | — |